Tim Brümmendorf: FlowFISH in New ASH Guidelines for Aplastic Anemia
Tim Brümmendorf, Director at Center for Integrated Oncology Aachen-Bonn-Cologne- Düsseldorf (CIO-ABCD), Director at Dept. of Hematology and Oncology, shared European School of Haematology’s post on LinkedIn:
“25 years after our first report on the use of flowFISH for telomere length measurement in peripheral blood samples of patients with aplastic anemia (Brümmendorf et al. Blood, 2001 vol. 97(4) pp. 895-900), we finally made it into the new American Society of Hematology guidelines for diagnosis and treatment of aplastic anemia !
Great work as a chair of the board and great talk by Phillip Scheinberg at ESHBMFS 2026 European School of Haematology (ESH) DGHO e.V. onkopedia
Thanks to my team at Uniklinik RWTH Aachen and also for the long-standing great collaboration with Repeat Diagnostics Inc. (RepeatDx) aimed at the continuous improvement of the methodology”
Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery